Is nifedipine (calcium channel blocker) extended-release (ER) available in a liquid formulation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nifedipine ER Liquid Formulation Availability

No, nifedipine extended-release (ER) is not available in a liquid formulation and must be swallowed whole as an intact tablet. 1

Formulation Requirements

  • Extended-release nifedipine tablets must be swallowed whole and cannot be crushed, split, or dissolved, as this would destroy the controlled-release mechanism and potentially cause dangerous rapid drug release 1

  • The ER formulation relies on specific tablet technology (such as the GITS system) to provide gradual, sustained drug delivery over 24 hours, which cannot be replicated in liquid form 2, 3, 4

Alternative Formulations for Patients Unable to Swallow Tablets

If a patient cannot swallow extended-release tablets, consider these alternatives:

  • Immediate-release nifedipine can be used, though it requires more frequent dosing (typically TID-QID) and has a less favorable side effect profile with more reflex tachycardia 2, 5

  • Other calcium channel blockers like amlodipine or isradipine can be compounded into stable extemporaneous liquid suspensions 1

  • Amlodipine is specifically noted as being able to be compounded into stable suspensions and offers once-daily dosing 1

Critical Safety Consideration

  • Immediate-release nifedipine should not be used without concomitant beta-blockade in patients with cardiovascular disease due to increased risk of adverse cardiovascular events 6, 7

  • The short-acting capsule formulation of nifedipine should no longer be prescribed due to safety concerns 1

Related Questions

What is the appropriate dosing for Nifedipine (Calcium Channel Blocker)?
What does Nifedipine (calcium channel blocker) SR (sustained-release) mean?
What are the guideline-recommended indications for nifedipine (Calcium Channel Blocker), and are there any concurrent or sequential medications required for effective treatment?
What is the recommended use and dosage of nifedipine for treating hypertension and angina?
Can Nifedipine (calcium channel blocker) Extended Release (ER), 24-hour tablets be cut in half and taken?
What is the next treatment step for an older adult patient with acute shoulder pain due to degenerative changes, history of nonsteroidal anti-inflammatory drugs (NSAIDs) misuse, and noncompliance?
What is the best treatment approach for a 45-year-old female patient with a history of panic disorder, depression, and Attention Deficit Hyperactivity Disorder (ADHD), currently experiencing worsening anxiety and depressive symptoms, including depressed mood, low energy, sleep disturbances, and escalating panic attacks, who has previously been treated with Lexapro (escitalopram) and Adderall (amphetamine and dextroamphetamine), and is currently on hormone replacement therapy for perimenopausal syndrome?
What is the best treatment for a 64-year-old male with diabetes, hypertension, cirrhosis, and recent hepatic encephalopathy, presenting with lethargy, severe hyperglycemia, metabolic alkalosis, hypoxemia, and elevated lactic acid?
Is it safe to crush potassium chloride (KCl) tablets, especially for patients with difficulty swallowing, such as the elderly or those with neurological conditions?
Can pregabalin (an anxiolytic medication) alleviate headaches and other uncomfortable effects associated with tapering off duloxetine (a serotonin-norepinephrine reuptake inhibitor) in a patient with a history of anxiety, who has failed treatment with selective serotonin reuptake inhibitors (SSRIs) and is currently reducing their duloxetine dose from 60mg to 30mg every three days?
Is isotretinoin (13-cis-retinoic acid) safe for treating acne in patients with end-stage renal disease (ESRD) undergoing haemodialysis (HD)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.